Strengthening stakeholder engagement through ethics review in biomedical HIV prevention trials: opportunities and complexities

• Published in: Journal of the International AIDS Society 2018-10, Vol.21 (S7), p.e25172-n/a
• Main Authors: Slack, Catherine, Wilkinson, Abigail, Salzwedel, Jessica, Ndebele, Paul
• Format: Article
• Language: English
• Subjects: Acquired immune deficiency syndrome; AIDS; Analysis; Bioethics; Clinical trials; Collaboration; community engagement; Delivery of Health Care - ethics; Disease prevention; Ethical aspects; Ethics; Ethics Committees, Research; ethics review; HIV; HIV Infections - prevention & control; HIV prevention trials; Human immunodeficiency virus; Humans; Informed consent; Institutional Review Boards; Institutional review boards (Research ethics); Medical ethics; Medical research; Prevention; Research Design; Research ethics; Research Ethics Committee; Research Personnel; Researchers; Review; Sexually transmitted disease prevention; Stakeholder engagement; Stakeholder Participation; Stakeholders; Vaccines
• ISSN: 1758-2652; 1758-2652
• DOI: 10.1002/jia2.25172

Introduction Clinical trials of biomedical HIV prevention modalities require the cooperation of multiple stakeholders. Key stakeholders, such as community members, may have stark vulnerabilities. Consequently, calls for HIV prevention researchers to implement “stakeholder engagement” are increasingly common. Such engagement is held to benefit inter‐stakeholder relations, stakeholders themselves and the research itself. The ethics review process presents a unique opportunity to strengthen stakeholder engagement practices in HIV prevention trials. However, this is not necessarily straightforward. In this article, we consider several complexities. First, is stakeholder engagement a legitimate component of what Research Ethics Committees (RECs) should review for HIV prevention trials? Second, what are the core features of engagement that should be under ethics review? Third, what are the key practices that should be highlighted in ethics review? Methods To address these questions, we examined the international ethics guidelines specialized for such trials (UNAIDS 2012, UNAIDS‐AVAC GPP 2011) and directly applicable to such trials (CIOMS 2016; WHO 2011). Thematic analysis was used to code and analyse these guidelines. Results and discussion Ethics guidelines support REC review of engagement. Guidance recommends that engagement be broad and inclusive; early and sustained; and dynamic and responsive. Broad engagement practices include evaluating the context, planning in writing, and resourcing. RECs should assess engagement as part of a comprehensive review, and recommend revisions where necessary. Researchers should profile key elements of engagement valued in ethics guidance, when they draft ethics submissions. Importantly, the ethics review process should not undermine the ‘dynamic responsiveness’ required for excellent engagement in this field. Conclusions As evidence‐informed engagement strategies emerge, these should inform the ethics submission and review process. Both parties in the review process should strive to avoid a superficial, check‐list type approach that caricatures what should be a thorough, nuanced ethics review of a rich, responsive engagement process.